Status:
COMPLETED
A Prospective Study on the Therapeutic Outcomes of Mebo and Tantum Verde in Patients With Oral Mucositis
Lead Sponsor:
Cairo University
Conditions:
Oral Mucositis (Ulcerative) Due to Radiation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study aimed to assess the efficacy of MEBO® in the treatment of already established oral mucositis. This is a randomized controlled clinical trial. The study included 36 patients with established...
Eligibility Criteria
Inclusion
- Patients who later on during radiotherapy developed oral mucositis with a severity of WHO score II or more and were over 18 years were then included in the study and allocated to one of the treatment groups .
Exclusion
- We excluded patients who were receiving any prophylactic agents and/or corticosteroids and those who would not sign the informed consent.
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 14 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT07186114
Start Date
March 1 2023
End Date
December 14 2024
Last Update
September 22 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry - Cairo University
Cairo, Egypt, 11553
2
Cairo University
Cairo, Egypt